SAMHSA is offering the Strategic Prevention Framework for Prescription Drugs (SPF Rx) grant program to states, U.S. territories, pacific jurisdictions, and tribal entities. This grant aims to address the priority issue of prescription drug misuse by raising awareness, collaborating with pharmaceutical and medical communities to combat overprescribing to young adults, and implementing prevention activities in schools and communities. Successful applicants must have operational Prescription Drug Monitoring Programs (PDMPs), with a focus on reducing opioid overdoses and utilizing PDMP data. The program emphasizes community engagement and education to prevent prescription drug abuse among various stakeholders.
Opportunity ID: 282577
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | SP-16-006 |
| Funding Opportunity Title: | Strategic Prevention Framework for Prescription Drugs (SPF Rx) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | CategoryExplanation |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 25 |
| Assistance Listings: | 93.243 — Substance Abuse and Mental Health Services_Projects of Regional and National Significance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 29, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 31, 2016 |
| Current Closing Date for Applications: | May 31, 2016 |
| Archive Date: | Jun 30, 2016 |
| Estimated Total Program Funding: | $9,290,395 |
| Award Ceiling: | $371,616 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility is limited to these entities because they have the greatest likelihood of achieving success through the SPF Rx grant program. Having completed the SPF process, these entities have the necessary experience and background for implementation: 1) an established state/tribal infrastructure and system in place—rooted in both the SABG and the SPF prevention model—that allows them to quickly build capacity in communities of need, mobilize those communities, and ensure accurate data collection and reporting at the community level; 2) integration of the SPF-based process into their overall state and tribal prevention systems, ensuring a strong, data-driven focus on identifying, selecting, and implementing effective, evidence-based prevention programs, policies, and practices; 3) experience in working collaboratively with communities to achieve substance misuse prevention goals; 4) familiarity and experience with the alignment of behavioral health with primary prevention; 5) a history of building comprehensive state and tribal level prevention systems over time; and 6) the required state run prescription drug monitoring program. |
Additional Information
| Agency Name: | Substance Abuse and Mental Health Services Admin |
| Description: | The SPF Rx grant program provides an opportunity for states, U.S. territories, pacific jurisdictions (herein referred to as “states”), and tribal entities that have completed a Strategic Prevention Framework State Incentive Grant (SPF SIG) to target the priority issue of prescription drug misuse. The program is designed to raise awareness about the dangers of sharing medications and work with pharmaceutical and medical communities on the risks of overprescribing to young adults. SPF Rx will also raise community awareness and bring prescription drug abuse prevention activities and education to schools, communities, parents, prescribers, and their patients. In addition, SAMHSA will track reductions in opioid overdoses and the incorporation of Prescription Drug Monitoring Program (PDMP) data into needs assessments and strategic plans as indicators of the program’s success.
PDMPs are state-run databases used to track the prescribing and dispensing of controlled prescription drugs to patients. They are designed to monitor this information for suspected abuse or diversion (i.e., channeling drugs into illegal use), and can give a prescriber or pharmacist critical information regarding a patient’s controlled substance prescription history. State applicants must have a fully operational PDMP in order to apply for the SPF Rx program. Tribes must coordinate with the state run PDMPs to identify opportunities for collaboration that will limit overprescribing in tribal communities. |
| Link to Additional Information: | Strategic Prevention Framework for Prescription Drugs (SPF Rx) |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eileen Bermudez
Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration Rockville, Maryland 20857 (240) 276-1412 Email:FOACSAP@samhsa.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Eileen Bermudez Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration Rockville, Maryland 20857 (240) 276-1412 Email: FOACSAP@samhsa.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.243 | PKG00222052 | Mar 29, 2016 | May 31, 2016 | View |
Package 1
Mandatory forms
282577 SF424_2_1-2.1.pdf
282577 PerformanceSite_2_0-2.0.pdf
282577 Project-1.1.pdf
282577 HHS_CheckList_2_1-2.1.pdf
282577 Budget-1.1.pdf
282577 SF424A-1.0.pdf
Optional forms
282577 FaithBased_SurveyOnEEO-1.2.pdf
282577 Other-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
